Pharmacovigilance at the Clinical Trial Unit (CTU) focuses on the timely detection, assessment, and reporting of adverse drug reactions to ensure participant safety. Following Good Clinical Practice (GCP) guidelines, our team maintains strict safety monitoring and regulatory compliance throughout all clinical studies.